Bob Diamond's firm combines with Sonnet Biopharma in crypto venture

Welcome back to Squawkbox. New this morning, Bob Diamond, former CEO of Barkclay, is diving into the growing trend of investors buying companies to turn them into crypto assets. Diamond's Atlas Merchant Capital combining with Sonnet Biootherrapeutics to form Hyperlquid Strategies.Uh it's a little complicated, but the focus is on building a large reserve of what is called Hype tokens, which is a key to the Hyperlquid blockchain. We're going to have him explain this in just a moment. Bob Diamond, co-founder a ...